Journal of Infection and Chemotherapy

Publisher: Elsevier B.V.
Country: Netherlands · Western Europe
Type: journal
ISSN: 1341321X

14377780

Scopus 0,503 SJR

Scopus Q3 SJR Q

WoS Q3 JCR Q

WoS 1,7 JIF

Scopus 79 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

SJR 0,503
Quartile Q3
H-Index 79
Cites/doc 1,66
Docs (3y) 756
Cites (3y) 1.217

Clarivate

Web of Science · JCR · 2025

JCR Q Q3
JIF 1,7
5Y JIF 1,6
JCI 0,52

WoS indexes

SCIE

Subject classification

Categories (SJR)

Infectious Diseases Q3
Microbiology (medical) Q3
Pharmacology (medical) Q3

Areas

Medicine

WoS categories

Infectious Diseases | Pharmacology & Pharmacy

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year	SJR Q	JCR Q (1997+)	SJR	JIF (1997+)	5Y JIF (1997+)	JCI (1997+)	JCI Q (1997+)	H-Index
2025	Q3	Q3	0,503	1,7	1,6	0,52	Q3	79
2024	Q2	Q4	0,584	1,5	1,6	0,58	Q3	76
2023	Q2	Q3	0,579	1,9	1,8	0,6	Q2	76
2022	Q2	Q3	0,576	2,2	2,1	0,6	Q3	76
2021	Q2	Q4	0,588	2,1	2,1	0,53	Q3	76
2020	Q2	Q4	0,838	2,2	2,1	0,59	Q3	76
2019	Q2	Q4	0,691	1,7	1,7	0,56	Q3	76
2018	—	Q4	—	1,5	1,7	0,54	Q3	—
2017	Q2	Q4	0,848	1,8	1,6	0,58	Q3	76
2016	Q2	Q3	0,749	1,8	1,6	—	—	76
2015	Q2	Q3	0,739	1,4	1,4	—	—	76
2014	Q2	Q3	0,68	1,5	1,5	—	—	76
2013	Q2	Q3	0,637	1,4	—	—	—	76
2012	Q2	Q3	0,694	1,6	—	—	—	76
2011	Q2	Q3	0,784	1,8	—	—	—	76
2010	Q2	—	0,658	—	—	—	—	76

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year	Category	Edition	JCR Q (1997+)	JCI Q (1997+)	Rank
2025	INFECTIOUS DISEASES	SCIE	Q4	Q3	110/141
2025	PHARMACOLOGY & PHARMACY	SCIE	Q3	Q3	267/356
2024	INFECTIOUS DISEASES	SCIE	Q4	Q3	107/137
2024	PHARMACOLOGY & PHARMACY	SCIE	Q4	Q3	267/352
2023	INFECTIOUS DISEASES	SCIE	Q3	Q2	90/132
2023	PHARMACOLOGY & PHARMACY	SCIE	Q3	Q3	231/354
2022	INFECTIOUS DISEASES	SCIE	Q4	Q3	76/96
2022	PHARMACOLOGY & PHARMACY	SCIE	Q3	Q3	208/278
2021	INFECTIOUS DISEASES	SCIE	Q4	Q3	81/95
2021	PHARMACOLOGY & PHARMACY	SCIE	Q4	Q3	229/279
2020	INFECTIOUS DISEASES	SCIE	Q4	Q3	74/93
2020	PHARMACOLOGY & PHARMACY	SCIE	Q4	Q3	216/276
2019	INFECTIOUS DISEASES	SCIE	Q4	Q3	77/92
2019	PHARMACOLOGY & PHARMACY	SCIE	Q4	Q3	220/271
2018	INFECTIOUS DISEASES	SCIE	Q4	Q3	75/89
2018	PHARMACOLOGY & PHARMACY	SCIE	Q4	Q3	216/267
2017	INFECTIOUS DISEASES	SCIE	Q4	Q3	69/88
2017	PHARMACOLOGY & PHARMACY	SCIE	Q4	Q3	197/261
2016	INFECTIOUS DISEASES	SCIE	Q3	—	62/84
2016	PHARMACOLOGY & PHARMACY	SCIE	Q3	—	177/257
2015	INFECTIOUS DISEASES	SCIE	Q3	—	62/83
2015	PHARMACOLOGY & PHARMACY	SCIE	Q4	—	198/255
2014	INFECTIOUS DISEASES	SCIE	Q4	—	62/78
2014	PHARMACOLOGY & PHARMACY	SCIE	Q3	—	183/255
2013	INFECTIOUS DISEASES	SCIE	Q4	—	59/72
2013	PHARMACOLOGY & PHARMACY	SCIE	Q3	—	181/256
2012	INFECTIOUS DISEASES	SCIE	Q4	—	56/70
2012	PHARMACOLOGY & PHARMACY	SCIE	Q3	—	177/261
2011	INFECTIOUS DISEASES	SCIE	Q3	—	49/70
2011	PHARMACOLOGY & PHARMACY	SCIE	Q3	—	156/261